Primary objective: to study, in subjects with elevated blood pressure levels, the effects of an encapsulated grape seed extract high in polyphenols on daytime ambulatory systolic and diastolic blood pressure.Secondary objective: to explore…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
risicofactor HVZ: verhoogde bloeddruk
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Mean ambulatory blood pressure, measured during 12 hours on 2 measurement days.
Secondary outcome
Mechanistic markers
Urine metabolites
Background summary
Previous research showed that a grapeseed extract can reduce blood pressure.
The present study will be performed to test, in a second independent study,
whether or not a grapeseed extract has a blood pressure lowering effect. Next
to that, some mechanistic markers will be measured when a blood pressure
lowering effect is seen, which can provide insight into the mechanism of
action.
Study objective
Primary objective: to study, in subjects with elevated blood pressure levels,
the effects of an encapsulated grape seed extract high in polyphenols on
daytime ambulatory systolic and diastolic blood pressure.
Secondary objective: to explore mechanistic pathways responsible for the blood
pressure lowering efficacy.
Study design
- placebo controlled, double blind, randomized parallel design
- 70 subjects
- 2 test products
capsules with grapeseed extract
placebo capsules
- 1 week run-in, 8 weeks intervention
The following measurements will take place at the end of run-in and at the end
of intervention:
Day 1: 12h ambulantory blood pressure measurements (every 20 min)
Day 2: 24h urine collection, 2 blood samples (before and after breakfast)
Day 3: 12h ambulantory blood pressure measurements (every 20 min)
- dietary restrictions during complete study: max 2 cups of tea per day, no red
wine, red grapejuice, dark chocolate, on certain days no alcoholic
consumptions, repetition of meals on measurement days before and after
intervention
Intervention
Capsules with grapeseed extract
Placebo capsules
Study burden and risks
There are, as far as known, no medical risks associated with participation to
this study.
Olivier van Noortlaan 120
3133AT Vlaardingen
Nederland
Olivier van Noortlaan 120
3133AT Vlaardingen
Nederland
Listed location countries
Age
Inclusion criteria
Age 35-75 years
SBP 120-159 mmHg
BMI 18.5-30.0 kg/m2
Exclusion criteria
Unilever employees
DBP > 99 mmHg
Smokers
Medical conditions or medicine use which may influence study parameters
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
Other | nader te bepalen |
CCMO | NL26071.081.08 |